The natural history of thyroid autonomy and hot nodules

Annales d'Endocrinologie

Volumn 64, Issue 1, 2003, Pages 17-22

  Corvilain, B ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Hot nodule; Hyperthyroidism; Thyroid autonomy; TSH receptor

Indexed keywords

LIOTHYRONINE; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE;

CONFERENCE PAPER; GENOTYPE; HISTORY; HUMAN; HYPERTHYROIDISM; PATHOGENESIS; PHENOTYPE; SCINTISCANNING; THYROID ADENOMA; THYROID NODULE; THYROTOXICOSIS;

ADENOMA; GENOTYPE; HUMANS; HYPERTHYROIDISM; PHENOTYPE; THYROID HORMONES; THYROID NEOPLASMS; THYROID NODULE;

EID: 0037309822     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Als C, Listewnik M, Roesler H, Bartkowiak E. Immunogenic and non-immunogenic hyperthyroidism. Recent trends in prealpine Switzerland and in coastal Poland. Nuklearmedizin 1995; 34(3): 92-99.
2. Belfiore A, Sava L, Runello F, Tomaselli L, Vigneri R. Solitary autonomously functioning thyroid nodules and iodine deficiency. J Clin Endoc Metab 1983; 56(2): 283-287.
3. Corvilain B, Contempre B, Longombe AO, Goyens P, Gervy Decoster C, Lamy F et al. Selenium and the thyroid: how the relationship was established. Am J Clin Nutr 1993; 57: 244S-248S.
4. 2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endoc Metab 1994; 79: 152-159.
5. Corvilain B, Van Sande J, Dumont JE, Bourdoux P, Ermans AM. Autonomy in endemic goiter. Thyroid 1998; 8(1): 107-113.
6. Corvilain B, Van Sande J, Dumont JE, Vassart G. Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) 2001; 55(2): 143-158.
7. De Deken X, Vilain C, Van-Sande J, Dumont JE, Miot F. Decrease of telomere length in thyroid adenomas without telomerase activity. J Clin Endoc Metab 1998; 83(12): 4368-4372.
8. Deleu S, Allory Y, Radulescu A, Pirson I, Carrasco N, Corvilain B et al. Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology. Thyroid 2000; 10(2): 131-140.
9. Dremier S, Coppee F, Delange F, Vassart G, Dumont JE, Van Sande J. Clinical review 84: Thyroid autonomy: mechanism and clinical effects. J Clin Endoc Metab 1996; 81(12): 4187-4193.
10. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C et al. Germline mutations in the thyrotropin receptor gene cause non- autoimmune autosomal dominant hyperthyroidism. Nat Genet 1994; 7(3): 396-401.
11. Ermans AM, Camus M. Modifications of thyroid function induced by chronic administration of iodide in the presence of "autonomous" thyroid tissue. Acta Endocrinol (Copenh) 1972; 70(3): 463-475.
12. Hamburger JI. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endoc Metab 1980; 50(6): 1089-1093.
13. Hamburger JI. The autonomously functioning thyroid nodule: Goetsch's disease. Endocr Rev 1987; 8(4): 439-447.
14. Kopp P, Kimura ET, Aeschimann S, Oestreicher M, Tobler A, Fey MF et al. Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endoc Metab 1994; 79(1): 134-139.
15. Kopp P, Van Sande J, Parma J, Duprez L, Gerber H, Joss E et al. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 1995; 332(3): 150-154.
16. Krohn K, Fuhrer D, Holzapfel HP, Paschke R. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. J Clin Endoc Metab 1998; 83(1): 130-134.
17. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med 1991; 229(5): 415-420.
18. Livadas DP, Koutras DA, Souvatzoglou A, Beckers C. The toxic effect of small iodine supplements in patients with autonomous thyroid nodules. Clin Endocrinol (Oxf) 1977; 7(2): 121-127.
19. Persani L, Lania A, Alberti L, Romoli R, Mantovani G, Filetti S et al. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas. J Clin Endoc Metab 2000; 85(8): 2872-2878.
20. Reinwein D, Benker G, Konig MP, Pinchera A, Schatz H, Schleusener A. The different types of hyperthyroiclism in Europe. Results of a prospective survey of 924 patients. J Endocrinol Invest 1988; 11(3): 193-200.
21. Rojeski MT, Gharib H. Nodular thyroid disease. Evaluation and management. N Engl J Med 1985; 313(7): 428-436.
22. Sandrock D, Olbricht T, Emrich D, Benker G, Reinwein D. Longterm follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh) 1993; 128(1): 51-55.
23. Silverstein GE, Burke G, Cogan R. The natural history of the autonomous hyperfunctioning thyroid nodule. Ann Intern Med 1967; 67(3): 539-548.
24. Van Sande J, Lamy F, Lecocq R, Mirkine N, Rocmans P, Cochaux P et al. Pathogenesis of autonomous thyroid nodules: in vitro study of iodine and adenosine 3′,5′-monophosphate metabolism. J Clin Endoc Metab 1988; 66: 570-59.
25. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont JE, Vassart G. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endoc Metab 1995; 80: 2577-2585.